Risk factor
Poor trading liquidity
Profitability factor
Very strong margins and returns
About
Voxel S.A. manages an extensive chain of facilities dedicated to diagnostic medical imaging. The company's offerings encompass a broad range of advanced imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single photon emission computed tomography (SPECT). Furthermore, Voxel S.A. provides teleradiology and outsourcing solutions within the diagnostic imaging sector, alongside developing information systems specifically designed for hospitals and diagnostic centers. The firm also undertakes ventures focused on equipping and implementing new diagnostic laboratories. Established in 2005 and headquartered in Kraków, Poland, Voxel S.A. maintains its operational presence through 33 specialized laboratories situated in 21 Polish cities.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA, underpriced
Target Price
The average target price of VOX.WA is 143 and suggests 3.28% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to